about
Baclofen for alcohol withdrawalEfficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal SyndromeBaclofen for alcohol withdrawalAnticonvulsants for alcohol withdrawalEfficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal SyndromeBenzodiazepines for alcohol withdrawalAnticonvulsants for alcohol withdrawalBenzodiazepines for alcohol withdrawalGlutamatergic substrates of drug addiction and alcoholismLife-threatening brain failure and agitation in the intensive care unit.Alcohol Withdrawal Syndrome: Benzodiazepines and BeyondThe development of acamprosate as a treatment against alcohol relapseHuman variation in alcohol response is influenced by variation in neuronal signaling genesCurrent approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles"Acamprosate produces its anti-relapse effects via calciumCognitive and neurobiological mechanisms of alcohol-related aggressionThe Interplay between the Hippocampus and Amygdala in Regulating Aberrant Hippocampal Neurogenesis during Protracted Abstinence from Alcohol Dependence.Identifying the neural circuitry of alcohol craving and relapse vulnerability.N-methyl-d-aspartic acid receptors are altered by stress and alcohol in Wistar-Kyoto rat brain.ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes.Alcohol withdrawal kindling: is there a role for anticonvulsants?Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.Ionotropic glutamate receptor gene GRIK3 SER310ALA functional polymorphism is related to delirium tremens in alcoholics.Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.Glutamate and its role in psychiatric illness.Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence.Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring ratsDexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUPharmacotherapy of alcohol use disorders.Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.Role of altered structure and function of NMDA receptors in development of alcohol dependence.Neurorobiology and evidence-based biological treatments for substance abuse disorders.Pharmacotherapy of dual substance abuse and dependence.Successful use of oxazepam in the treatment of delirium tremensMemantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism.Acute ethanol impairs photic and nonphotic circadian phase resetting in the Syrian hamsterGlutamate export at the choroid plexus in health, thiamin deficiency, and ethanol intoxication: review and hypothesis.A daily process examination of the bidirectional relationship between craving and alcohol consumption as measured via interactive voice response.Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonistInitiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence
P2860
Q24234933-C0F40927-85B7-4FD8-B35F-0B7A30E16628Q24235239-11ADB087-1AF4-410B-916A-678DB43224D2Q24235642-44EABAF3-541A-40AC-BFBC-4EB2032A5693Q24236686-76F5F7B9-61A5-432E-9BB4-B761E2F08A6DQ24236712-41B60A83-6F3D-4839-8352-6B78DB72D8B0Q24236758-C9F0A2F1-32B1-4F38-AF6A-280E62BBDBDCQ24246603-40BBF523-9288-417A-9B9C-9C536F703EB3Q24246669-0A3A9C32-152A-411C-9F28-6CBAE5514579Q24648924-A9AC86F9-224B-4EC4-830E-E2E6A509049DQ24797352-7BC689B1-03A2-4EFF-856B-5E6551A40072Q26779100-734938AE-2EC1-453C-B846-84B16AE79954Q26862199-27C42B4F-24AA-4C2F-AFCA-80AB5EB1909EQ28274926-165161EE-74F4-4028-B7CB-39E67C89A75AQ28295614-B0CB3512-2AE4-4864-88FB-3B7D7F91FB4CQ28299533-95355240-43C0-4B68-812B-76D98D9786E3Q29398661-7019021C-ADAD-41EA-A9EC-9E1F5CFB1666Q30452872-D99F1711-B71B-4826-A480-5B73D107AE4CQ33887107-1D8D2518-CCEB-4393-8CF2-AFBF90DFDFB5Q33976515-F4330CE6-0008-4D8E-96AE-F744D00C692FQ34035612-90C115F4-F7AD-4505-BD01-CB7039A5C9CFQ34396593-79737C3E-FC4F-46F8-8C98-AEA2D66E1753Q34459205-A20A2816-313C-4866-B6F5-48EE0B85923FQ34471132-33B136E1-D8FC-43B2-963B-C3B7510B4865Q34773574-6D0A1AF2-F935-4F18-9404-3E8C5241479AQ34982546-83B2A69E-2340-47FC-9C46-FC3973D5B5A8Q35206404-9290069B-731A-49E5-9A08-BE8F9128EF69Q35956322-051A5380-BF49-4399-AD31-852346A366EFQ36297368-2F8F0A73-AFE3-4EE1-86C0-435FA9A91A47Q36311029-368F6389-7730-4A00-822A-09A4EEB32DC7Q36493462-B343A1C1-D04F-4949-B178-6C997D6A3B58Q36499757-E074CA80-6DDE-4C86-A008-4046B72B11A6Q36639800-1346CB48-A644-45BB-B6CD-8556CE7080D8Q36751967-E9B72765-9ED5-4E7D-B0DC-2A06AFE6D660Q36755311-C9D07F92-77F3-4CD2-8320-E8C464254FCBQ36906101-3AA494EE-B3AF-464C-B186-332154B9EED9Q37100502-47C5CF62-1D49-4F47-9C3B-3220EFEAA179Q37212303-3CCFF684-60B7-440F-96D8-02372D93FC1AQ37273819-346D5E1C-A6EE-4EC4-936D-A43355C95D59Q37307000-3772B397-EBD5-42AA-BC00-ECA220FC90A0Q37311915-531BC6D8-FEEA-4CAB-934C-13550C83AD1B
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The glutamatergic basis of human alcoholism.
@en
type
label
The glutamatergic basis of human alcoholism.
@en
prefLabel
The glutamatergic basis of human alcoholism.
@en
P2093
P356
P1476
The glutamatergic basis of human alcoholism.
@en
P2093
P304
P356
10.1176/AJP.152.3.332
P407
P577
1995-03-01T00:00:00Z